ACTIVE

LINTERPHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

244,7 k €

-14.8% YoY

Gross margin

439,5 k €

-14.7% YoY

Equity

1,2 M €

-30.6% YoY

Workforce

0,0 ETP

What does LINTERPHARMA do?

LINTERPHARMA is a Private limited company incorporated in 1984. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Linter.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0426.079.824

Incorporation

26/07/1984

Legal form

Private limited company

Registered office

Grote Steenweg(DRL) 302
3350 Linter · FlandreSee on map

Contributed capital

8 676,27 €

Latest accounts

31/12/2025

Average workforce

0,0 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	439,5 k €	-14.7%	515,3 k €	-11.5%	582,2 k €	+26.5%	460,3 k €	-10.2%	512,8 k €	-8.6%	561,1 k €	-5.3%	592,5 k €	+7.8%	549,4 k €	-4.5%	575,2 k €	+33.8%	429,8 k €	+66.1%	258,7 k €	-21.8%	330,7 k €	+7.8%	306,7 k €	+4.1%	294,5 k €	+9.0%	270,2 k €	-0.6%	271,9 k €	+21.8%	223,2 k €	+26.3%	176,7 k €	+22.3%	144,4 k €	+2.3%	141,2 k €
EBITDA	435,4 k €	-14.0%	506 k €	-4.9%	532 k €	+37.4%	387,1 k €	-13.2%	445,8 k €	+10.7%	402,8 k €	-6.3%	429,8 k €	+10.2%	389,9 k €	-2.6%	400,3 k €	+111%	190 k €	+438%	35,3 k €	-75.0%	141,2 k €	-13.4%	163,2 k €	+4.2%	156,7 k €	+16.1%	135 k €	-2.8%	138,8 k €	+60.5%	86,5 k €	+87.0%	46,2 k €	+135%	19,7 k €	+4.4%	18,8 k €
Operating result	323,3 k €	-19.3%	400,5 k €	-10.8%	449,1 k €	+32.0%	340,3 k €	-15.3%	401,7 k €	+11.6%	359,8 k €	-6.3%	384 k €	+11.7%	343,7 k €	-2.1%	351,1 k €	+158%	136,3 k €	+888%	-17,3 k €	-120%	86,6 k €	-23.7%	113,5 k €	+9.8%	103,3 k €	+23.7%	83,6 k €	+3.9%	80,4 k €	+169%	29,9 k €	+373%	-11 k €	+32.1%	-16,2 k €	+11.6%	-18,3 k €
Net result	244,7 k €	-14.8%	287,2 k €	-13.2%	331 k €	+31.1%	252,5 k €	-6.4%	269,6 k €	+11.7%	241,4 k €	-2.7%	248 k €	-3.2%	256,1 k €	+6.9%	239,5 k €	+160%	92,3 k €	+892%	9,3 k €	-88.0%	77,5 k €	-18.9%	95,6 k €	-29.9%	136,3 k €	+18.4%	115,1 k €	+2.6%	112,1 k €	+67.4%	67 k €	+313%	16,2 k €	-48.4%	31,5 k €	+14.6%	27,4 k €
Balance sheet
Equity	1,2 M €	-30.6%	1,7 M €	+13.0%	1,5 M €	+26.5%	1,2 M €	+5.8%	1,1 M €	+30.0%	853,7 k €	+24.6%	685 k €	+23.0%	557,1 k €	+20.3%	462,9 k €	+4.4%	443,4 k €	+26.3%	351,1 k €	+2.7%	341,8 k €	+29.3%	264,3 k €	-4.0%	275,2 k €	+0.1%	275 k €	+1.1%	271,8 k €	+4.3%	260,7 k €	+8.1%	241,2 k €	+5.8%	228 k €	+5.3%	216,5 k €
Total assets	1,6 M €	-25.5%	2,2 M €	+7.1%	2 M €	-1.6%	2,1 M €	+29.2%	1,6 M €	+18.6%	1,4 M €	+7.0%	1,3 M €	-14.6%	1,5 M €	-0.1%	1,5 M €	+14.0%	1,3 M €	+51.8%	859,6 k €	+1.0%	851,3 k €	+0.2%	849,5 k €	-6.6%	909,7 k €	-8.8%	997,4 k €	+3.1%	967,8 k €	+15.4%	838,4 k €	+0.7%	832,3 k €	+14.0%	730,3 k €	+7.7%	678,2 k €
Cash	520,5 k €	+24.1%	419,5 k €	-46.1%	778,2 k €	+22.8%	633,5 k €	-6.1%	674,8 k €	+84.6%	365,6 k €	+47.2%	248,3 k €	-45.9%	459,3 k €	-19.5%	570,6 k €	+90.9%	298,8 k €	+38.3%	216 k €	+33.1%	162,3 k €	-17.0%	195,6 k €	-16.8%	235,1 k €	-19.6%	292,3 k €	-6.1%	311,3 k €	+166%	117,2 k €	+121%	53,1 k €	+36.0%	39 k €	-60.1%	97,8 k €
Debts	467,6 k €	-5.4%	494,1 k €	-7.6%	534,7 k €	-39.8%	888,3 k €	+83.4%	484,3 k €	-1.0%	489,1 k €	-15.1%	576,1 k €	-37.5%	922,1 k €	-9.4%	1 M €	+18.9%	856 k €	+69.2%	505,9 k €	+0.6%	503 k €	-12.5%	575,2 k €	-8.0%	625 k €	-12.4%	713,3 k €	+5.6%	675,5 k €	+21.1%	557,8 k €	-3.6%	578,4 k €	+16.4%	496,9 k €	+10.3%	450,5 k €
Other
Workforce	0,0 ETP		0,0 ETP	-100%	0,6 ETP	-60.0%	1,5 ETP		–		2,5 ETP	0.0%	2,5 ETP	+4.2%	2,4 ETP	-14.3%	2,8 ETP	0.0%	2,8 ETP	-20.0%	3,5 ETP	+12.9%	3,1 ETP	+29.2%	2,4 ETP	+26.3%	1,9 ETP	0.0%	1,9 ETP	-13.6%	2,2 ETP	-8.3%	2,4 ETP	-4.0%	2,5 ETP	0.0%	2,5 ETP	+4.2%	2,4 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Ingrid Catfolis

Director

Active

Ended mandates

INGRID CATFOLIS

Manager · since 24 décembre 2013

Ended

BVBA SPIRITUS-CATFOLIS

Manager

Ended

Ingrid Catfolis

Andere functie

Ended

At this address

Other companies at this address

Company	CBE no.
APOTHEKER LAURA SPIRITUS● Active	0775.599.627

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	23/07/2026	24/06/2025	16/07/2024	25/07/2023	14/07/2022	28/06/2021
General meeting	30/05/2026	31/05/2025	25/05/2024	27/05/2023	28/05/2022	22/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	30/05/2026	23/07/2026	Dutch	PDF
Abridged model	31/12/2024	31/05/2025	24/06/2025	Dutch	PDF
Abridged model	31/12/2023	25/05/2024	16/07/2024	Dutch	PDF
Abridged model	31/12/2022	27/05/2023	25/07/2023	Dutch	PDF
Abridged model	31/12/2021	28/05/2022	14/07/2022	Dutch	PDF
Abridged model	31/12/2020	22/05/2021	28/06/2021	Dutch	PDF
Abridged model	31/12/2019	30/05/2020	17/07/2020	Dutch	PDF
Abridged model	31/12/2018	25/05/2019	25/07/2019	Dutch	PDF
Abridged model	31/12/2017	19/03/2018	07/05/2018	Dutch	PDF
Abridged model	31/12/2016	27/05/2017	20/06/2017	Dutch	PDF
Abridged model	31/12/2015	28/05/2016	16/06/2016	Dutch	PDF
Abridged model	31/12/2014	30/05/2015	09/07/2015	Dutch	PDF
Abridged model	31/12/2013	31/05/2014	12/06/2014	Dutch	PDF
Abridged model	31/12/2012	25/05/2013	02/07/2013	Dutch	PDF
Abridged model	31/12/2011	26/05/2012	19/06/2012	Dutch	PDF
Abridged model	31/12/2010	28/05/2011	28/06/2011	Dutch	PDF
Abridged model	31/12/2009	29/05/2010	09/06/2010	Dutch	PDF
Abridged model	31/12/2008	30/05/2009	09/06/2009	Dutch	PDF
Abridged model	31/12/2007	31/05/2008	27/06/2008	Dutch	PDF
Abridged model	31/12/2006	16/06/2007	04/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Ingrid Catfolis

Director

Active

Ended mandates

INGRID CATFOLIS

Manager · since 24 décembre 2013

Ended

BVBA SPIRITUS-CATFOLIS

Manager

Ended

Ingrid Catfolis

Andere functie

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other09/07/2026
—
PDF
Other08/10/2019
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
PDF
Mandates10/01/2014
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates01/04/2005
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025244,7 k €↓
2024
Annual accounts 2024287,2 k €↓
2023
Annual accounts 2023331 k €↑
2022
Annual accounts 2022252,5 k €↓
2021
Annual accounts 2021269,6 k €↑
2020
Annual accounts 2020241,4 k €↓
2019
Annual accounts 2019248 k €↓
2018
Annual accounts 2018256,1 k €↑
2017
Annual accounts 2017239,5 k €↑
2016
Annual accounts 201692,3 k €↑
2015
Annual accounts 20159,3 k €↓
2014
Annual accounts 201477,5 k €↓
2013
Annual accounts 201395,6 k €↓
2012
Annual accounts 2012136,3 k €↑
2011
Annual accounts 2011115,1 k €↑
2010
Annual accounts 2010112,1 k €↑
2009
Annual accounts 200967 k €↑
2008
Annual accounts 200816,2 k €↓
2007
Annual accounts 200731,5 k €↑
2006
Annual accounts 200627,4 k €
26/07/1984
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

LINTERPHARMA

Overview

What does LINTERPHARMA do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline